MRI diffusion and perfusion markers link MYD88/CD79B co-mutation to poorer outcomes in primary CNS lymphoma
A retrospective study of 92 patients found that quantitative diffusion and perfusion MRI parameters distinguished MYD88/CD79B co-mutated primary CNS lymphoma ...
